AVEO - Model AV-353 - Oncology (Anti-Notch 3 mAb)
AV-353 is the Company’s potent, selective, high affinity inhibitory antibody specific to Notch 3. The Notch 3 signaling pathway is important in cell-to-cell communication involving gene regulation mechanisms that control multiple cell differentiation processes during the entire life cycle. Scientific literature has implicated the Notch 3 receptor pathway in multiple diseases, including cancer, cardiovascular diseases and neurodegenerative conditions.
-
Most popular related searches
Customer reviews
No reviews were found for AVEO - Model AV-353 - Oncology (Anti-Notch 3 mAb). Be the first to review!